Corpus Intelligence IC Memo — KETTERING HEALTH MIAMISBURG 2026-04-26 09:33 UTC
IC Memo — KETTERING HEALTH MIAMISBURG
Investment Committee Memorandum | OH | 168 beds | Grade C | EBITDA uplift $14.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KETTERING HEALTH MIAMISBURG

CCN 360239 | MONTGOMERY, OH | 168 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KETTERING HEALTH MIAMISBURG is a 168-bed suburban community hospital in MONTGOMERY, OH with $199.9M in net patient revenue and a 7.8% operating margin. The hospital serves a payer mix of 17.1% Medicare, 5.1% Medicaid, and 77.8% commercial.

Thesis: Turnaround. Our ML models identify $14.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.8% to 15.2% (+736bps).

Net Revenue HCRIS$199.9M
Current EBITDA COMPUTED$15.6M
Operating Margin COMPUTED7.8%
Occupancy HCRIS55.0%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS19.8%
Distress Probability ML45.9%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
80
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 7.8% places it above the state median. Among 80 size-comparable peers (84-336 beds), the median margin is 0.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (84-336), prioritizing same-state peers. 80 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KETTERING HEALTH MIAMISBURG (Target)OH168$199.9M7.8%
RAINBOW BABIES & CHILDRENS HOSOH231$2.22B-5.0%
KETTERING HEALTH DAYTONOH317$667.6M3.3%
DAYTON CHILDRENS HOSPITALOH181$569.1M7.9%
GENESIS HEALTHCARE SYSTEMOH282$527.6M0.6%
ST. RITAS MEDICAL CENTER LLCOH329$497.6M6.5%
MARIETTA MEMORIAL HOSPITALOH188$475.8M-12.4%
ADENA REGIONAL MEDICAL CENTEROH209$470.7M3.5%
SOUTHERN OHIO MEDICAL CENTEROH192$424.3M-4.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.2M+210bp18mo
Cost to Collect4.5%2.5%$4.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.4M+122bp9mo
Clean Claim Rate88.0%96.0%$128K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.2M
Cost to Collect
$4.0M
Denial Rate Reduction
$4.0M
A/R Days Reduction
$2.4M
Clean Claim Rate
$128K
Total EBITDA Uplift$14.7M
Current EBITDA$15.6M
+ RCM Uplift+$14.7M
Pro Forma EBITDA$30.3M
Current Margin7.8%
Pro Forma Margin15.2%
WC Released (1x)$7.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$24.0M$250.2M10.41x59.8%
Base (11x exit)10.0x11.0x$24.0M$283.0M11.77x63.7%
Bull Case9.0x11.0x$21.6M$339.4M15.68x73.4%
Bull (12x exit)9.0x12.0x$21.6M$376.6M17.41x77.1%
Bear Case11.0x10.0x$26.4M$168.8M6.38x44.9%
Bear (11x exit)11.0x11.0x$26.4M$194.3M7.35x49.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 80 hospitals with 84-336 beds
  • Same-state prioritization (n=81)
  • Comp margins: P25=-9.8% / P50=0.5% / P75=6.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.